Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $8.74 USD
Change Today +0.47 / 5.68%
Volume 51.6K
VCYT On Other Exchanges
Symbol
Exchange
NASDAQ GM
Berlin
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Bonnie H. Anderson

Co-Founder, Chief Executive Officer, President, Director and Member of Non-Management Equity Award Committee,Veracyte, Inc.
AgeTotal Calculated CompensationThis person is connected to 20 board members in 2 different organizations across 2 different industries.

See Board Relationships
57$1,745,594
As of Fiscal Year 2014

Background*

Ms. Bonnie H. Anderson co-founded Veracyte, Inc., in 2008 and has been its Chief Executive Officer since February 2008 and President since August 2013. Ms. Anderson has over 25 years of experience in venture capital consulting and market development services. Her career spans nearly 30 years in the diagnostics and life sciences markets. She served as Vice President-Director of the Intrapreneurial Immunomics Operations at Beckman Coulter. She serves as a Director of Castle ...

Read Full Background

Corporate Headquarters*

7000 Shoreline Court
South San Francisco, California 94080

United States

Phone: 650-243-6300
Fax: 650-243-6301

Board Members Memberships*

Director
2008-Present
Co-Founder, Chief Executive Officer, President, Director and Member of Non-Management Equity Award Committee

Education*

BS
Indiana University, Bloomington

Other Affiliations*

Annual Compensation*

Salary$425,000
Total Annual Compensation$425,000

Stock Options*

Exercisable Options451,922
Unexercisable Options140,000
Total Number of Options591,922

Total Compensation*

Total Annual Cash Compensation$552,500
Total Short Term Compensation$425,000
Total Calculated Compensation$1,745,594
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VCYT:US $8.74 USD +0.47

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Nancy S. Lurker Chief Executive Officer and Director
PDI, Inc.
$736.5K
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
$800.0K
Kimberly J. Popovits Chairman, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$660.0K
Antonius P. Schuh Ph.D.Chief Executive Officer and Director
TrovaGene, Inc.
$539.0K
Michael J. Pellini M.D., MBAChief Executive Officer and Director
Foundation Medicine, Inc.
$416.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VERACYTE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.